Disease | tumoral calcinosis |
Comorbidity | C0085681|hyperphosphatemia |
Sentences | 1 |
PubMedID- 21854633 | Gain-of-function mutations of fgf23 lead to autosomal dominant hypophosphatemia/osteomalacia [5], while its loss-of-function mutations are causative of recessive familial tumoral calcinosis with hyperphosphatemia [6,7]. |
Page: 1